Dinuke R Warakaulle1, Fergus Gleeson. 1. Department of Radiology, The Churchill Hospital, Old Road, Oxford, OX3 7LJ, United Kingdom. dinuke2@hotmail.com
Abstract
OBJECTIVE: Our objective was to determine the MDCT appearance of gastrointestinal stromal tumors (GISTs) after treatment with imatinib mesylate. CONCLUSION: Cystic changes within primary and metastatic GISTs seen on MDCT in patients after imatinib mesylate therapy are evidence of disease response. Calcification may also occur in lesions that respond to therapy.
OBJECTIVE: Our objective was to determine the MDCT appearance of gastrointestinal stromal tumors (GISTs) after treatment with imatinib mesylate. CONCLUSION: Cystic changes within primary and metastatic GISTs seen on MDCT in patients after imatinib mesylate therapy are evidence of disease response. Calcification may also occur in lesions that respond to therapy.
Authors: Joan M Cheng; Sree Harsha Tirumani; Kyung Won Kim; Sachin S Saboo; Juan C Baez; Atul B Shinagare Journal: Cancer Imaging Date: 2013-12-11 Impact factor: 3.909